Researchers set out to determine whether cancer-related cognitive impairment impacts older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy.
The researchers evaluated the accuracy of WGS and WTS in determining diagnostic subgroups in 1100 patients with acute myeloid leukemia, B-cell precursor acute lymphoblastic leukemia, or T-cell acute...
In a recent study, researchers sought to identify predictors associated with a higher risk of central nervous system relapse in patients with acute myeloid leukemia. To see results of the study, including...
After its efficacy was demonstrated in a clinical trial, the US Food and Drug Administration approved a new treatment options for adult patients with 2 types of poor-prognosis acute myeloid leukemia.
The US Food and Drug Administration recently approved a new treatment option for patients with relapsed or refractory acute myeloid leukemia who have IDH2 mutations.
Researchers conducted a trial to explore the benefits of including androgens into the maintenance therapy for acute myeloid leukemia in elderly patients.
